Zykadia (ceritinib) 150 mg hard capsules, 150 capsules — original (Novartis, Switzerland) Non-small cell lung cancer Targeted cancer therapy. Delivery of medications from Europe, storage conditions observed, payment upon receipt. Order by phone +380996042415, Viber, WhatsApp

Medicinal use of Zikadia^®, as monotherapy of indications as a first-line drug for the treatment of adult patients who suffer for ALK (anaplastic lymphoma kinase) - positive for non-ligamentous leg cancer (NDLC).

The drug, as a monotherapy, is indicated for the treatment of adult patients who suffer from ALK (anaplastic lymphoma kinase) - positive advanced non-ligamentous lung cancer (NDLC), who previously received additional care crizotinib.